期刊文献+

地塞米松预处理在四氧嘧啶诱导1型糖尿病兔模型中的价值 被引量:2

Effect of dexamethasone pretreatment on alloxan induced diabetic rabbit model
原文传递
导出
摘要 目的 探讨地塞米松预处理在四氧嘧啶诱导1型糖尿病兔模型中的价值。方法按是否给予地塞米松预处理和四氧嘧啶给药次数将新西兰免分为四组,采用四氧嘧啶静脉注射诱导糖尿病模型,对病死率及成模率等进行比较。结果地基米松预处理组成模率为66.67%(1次给药法),83.33%(2次给药法);无预处理组为16.67%(1次给药法),41.67%(2次给药法)。四组中地塞米松预处理2次给药法成模率最高(83.33%)。地塞米松预处理组病死率为25.00%(1次给药法),0.00%(2次给药法);无预处理组为83.33%(1次给药法),41.67%(2次给药法)。四组中地塞米松预处理2次给药法病死率最低(0.00%)。结论地塞米松预处理,尤其是地塞米松预处理2次给药法可显著提高四氧嘧啶诱导糖尿病兔模型的成模率,明显降低病死率,缩短建模周期,是构建糖尿病兔模型的较理想方法,值得推广应用。 Objective To investigate the effect of dexamethasone pretreatment on alloxan induced diabetic rabbit model. Methods Male New Zealand rabbits were divided into four groups according to whether being pretreated with dexamethasone and administration times of alloxan. Fatality and success rate between the groups were compared. Results The success rate in dexamethasone pretreated group was 66.67% (once administration) and 83.33% (twice administration), that of unpretreated group was 16.67% (once administration) and 41.67% (twice administration). In the whole animals dexamethasone pretreated group with twice administration show the highest success rate. The fatality in dexametbasone pretreated group was 25.00% ( once administration) and 0.00% ( twice administration), that of un - pretreated group was 83.33% (once administration) and 41.67% (twiceadministration). In the whole animals dexamethasone pretreated group with twice administration show the lowest fatality. Conclusions Dexamethasone pretreatment especially combined with alloxan twice administration could enhance the success rate of diabetic rabbit induced by alloxan. Moreover, the fatality was decreased significantly and induction period was shortened. Therefore, it is the ideal strategy to induce diabetic rabbit model.
出处 《中国实用医刊》 2011年第18期1-2,6,共3页 Chinese Journal of Practical Medicine
基金 国家自然科学基金(30860276) 云南省应用基础研究计划(2007M272) 云南省科技厅-昆明医学院联合专项基金(2008CD042)
关键词 糖尿病 动物模型 四氧嘧啶 地塞米松 Diabetes Animal model Alloxan Dexamethasone
  • 相关文献

同被引文献30

  • 1梁志锋,林军,黄晶,杨斌,韦康来,柯美珍,陈美芳.阿托品对四氧嘧啶糖尿病动物模型的影响[J].中国临床康复,2006,10(28):76-78. 被引量:1
  • 2宋旸,朴松兰,盛春华,常颖,金正贤,张桂珍.STZ诱导C57BL小鼠T1DM模型优化的研究[J].中国实验诊断学,2007,11(1):36-39. 被引量:7
  • 3古筱茹.不同剂量四氧嘧啶皮下注射对大鼠糖尿病模型稳定性的影响[J].天津药学,2007,19(1):16-17. 被引量:5
  • 4Baker J,Ajani J,Scott6 F,et a1.D00etaxel-reded side effects and their managemen[J].Eur J Oneo Nuts,2008,12:253-268.
  • 5Rakieten N,Rakieten ML,Nadkarin MV. Studies on the diabeto- genic action of streptozotocin (NSC-37917) [J]. Cancer Chemother Rep, 1963,29(7) : 91-98.
  • 6Sasaki Y, Suzuki W, Shimada T, et al. Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodi- um glutamate-induced obese mice [J]. Life Sci, 2009,85 ( 13 - 14 ) : 490-498.
  • 7Barber A J, Antonetti D A. Mapping the blood vessels with paracel- lular permeability in the retinas of diabetic rats[J]. Invest Ophthal- tool Vis Sci, 2003,44(12) : 5410-5416.
  • 8Khaled A. Hussein,Karishma Choksi,et al. Bone morphogenetic protein 2, A potential new player in the pathogenesis of diabetic retinooathv[J]. Exnerimental Eve Research. 2014.125.70-88.
  • 9Liheng Shi,Michael L Ko,Cathy Chia-Yu Huang,et al. Chicken Embryos as a Potential New Model for Early Onset Type I Diabetes [J]. Journal of Diabetes Research, 2014 : 354094.
  • 10Kowalczuk L,Touchard E,Omri S,et al. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy[J]. PLoS One,2011,6 (3) : e17462.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部